RALEIGH, N.C., December 21, 2020 — Merz Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA) for the treatment of patients aged 2 years and older with chronic…
Read More
Dr. Drew Pinsky tests positive for coronavirus
Dr. Drew Pinsky on why governors pushing lockdowns are not ‘following the science’ <br> "FOX 11 Special Report" co-host Dr. Drew Pinsky announced Tuesday he had tested positive for COVID-19. The 62-year-old famous doctor has reportedly experienced symptoms of the virus…
Read More
Study identifies distinct sub-types of aggressive tumours to allow for targeted treatment
A new study led by clinician-scientists from the National Cancer Centre Singapore (NCCS), with collaborators from research institutions worldwide, has found that angiosarcomas have unique genomic and immune profiles which allow them to be classified into three different subtypes. With…
Read More
96-year-old is first Spaniard vaccinated for COVID-19
A 96-year-old living in a care home in central Spain became the first person in the country to be vaccinated against COVID-19 on Sunday, in an event broadcast by national television. She felt “nothing” from the shot, Araceli Rosario Hidalgo…
Read More
Voluntary or compulsory? New evidence on motivation for anti-COVID-19 policies
A study by the University of Konstanz shows that voluntary motivation to comply with anti-COVID-19 policies is relatively high in Germany, but can be undermined by enforcement—The consequence of this finding differs depending on the policy Policies to contain the…
Read More
Digging deep for differences in Duchenne muscular dystrophy
A UT Southwestern research team has cataloged gene activity in the skeletal muscle of mice, comparing healthy animals to those carrying a genetic mutation that causes Duchenne muscular dystrophy (DMD) in humans. The findings, published online recently in PNAS, could…
Read More
Rimegepant bests placebo for preventing migraine
(HealthDay)—Taken every other day, rimegepant demonstrates efficacy for the preventive treatment of migraine, according to a study published online Dec. 15 in The Lancet. Robert Croop, M.D., from Biohaven Pharmaceuticals in New Haven, Connecticut, and colleagues compared the efficacy of…
Read More
Researchers develop foldable tent for safe dental care during the pandemic
Dental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often related to the generation of aerosols as well as handling of oral fluids and blood. This puts dentists at a…
Read More
Study reveals new strategy for reducing tumor growth, metastasis
A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma. The findings, reported in the journal Cancer Immunology Research, add mechanistic…
Read More
TikTok Users Swear By This Device for a Chiseled Jawline—But It’s Actually Really Dangerous
Social media has a weird way of making you feel insecure about things you didn't even know you should be concerned with—and currently, it's been focusing on your jawline. The popular social media app TikTok is flooded right now with…
Read More